SCN9A and erythromelalgia: Intriguingly, the V400M gain‐of‐function point mutation of Nav1.7 that causes erythromelalgia can confer sensitivity to carbamazepine and provides insight into how the biophysical properties of sodium channel function could influence drug sensitivity in patients (Fischer et al., 2009).